Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xinlikang capsules for cancer-related fatigue in patients with malignant tumors during rehabilitation
ChiCTR2400086399Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Hunan University of Chinese Medicine
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of enalapril in cancer-related fatigue (CRF), sponsored by First Affiliated Hospital of Hunan University of Chinese Medicine. Primary endpoint: Cancer-related fatigue score. Started Jul 2024; status: recruiting.
02
Drugs
enalapril
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on ChiCTR2400086399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086399.